Brett Zbar
About Brett Zbar
Brett Zbar serves as the Managing Director and Global Head of Life Sciences at General Atlantic, leveraging his extensive background in medicine and finance. He holds an MD from Harvard Medical School and has held leadership roles at various prominent firms, including Aisling Capital and Foresite Capital Management.
Work at General Atlantic
Brett Zbar serves as the Managing Director and Global Head of Life Sciences at General Atlantic. He has held this position since 2020, contributing to the firm's focus on growth equity investments in the life sciences sector. His role involves overseeing strategic initiatives and partnerships within the life sciences domain, leveraging his extensive background in medicine and investment.
Education and Expertise
Brett Zbar earned his medical degree (MD) from Harvard Medical School, where he studied from 1994 to 1998. Prior to that, he obtained a Bachelor of Arts degree in Molecular Biophysics and Biochemistry, as well as English, from Yale University from 1990 to 1994. His educational background provides a strong foundation for his expertise in life sciences and healthcare investments.
Background
Brett Zbar has a diverse professional background in both medicine and finance. He began his career as Osler Medical Housestaff at Johns Hopkins Hospital in the Department of Medicine from 1998 to 1999. Following this, he transitioned into the finance sector, working as an Associate Principal at McKinsey & Company from 1999 to 2004, and later as a Partner at Aisling Capital LLC from 2004 to 2014.
Previous Roles and Experience
Before joining General Atlantic, Brett Zbar was the Managing Director at Foresite Capital Management from 2015 to 2020. He also held a senior role at McKinsey & Company, where he was a senior member of the Pharmaceuticals and Medical Products practice. His extensive experience spans over two decades in both healthcare and investment, providing him with a unique perspective on the life sciences industry.
Board Memberships and Observations
Brett Zbar has served as a board member or observer for several companies in the life sciences sector. His involvement includes companies such as Aragon, Catalent, ConnectiveRx, Kinnate Biopharma, and ORIC Pharmaceuticals, among others. This role allows him to influence strategic decisions and contribute to the growth of innovative companies in the healthcare landscape.